#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 45

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

B-cell lymphoma+5

Not recruiting

InvestigationalNo placebo

Study on the Effects and Safety of Odronextamab for Adults with Previously Treated B-cell Non-Hodgkin Lymphoma

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Odronextamab

Contact Research Centre

Macular telangiectasia

Not recruiting

Registered drugNo placebo

Study Comparing Aflibercept and Placebo for Patients with Macular Telangiectasia Type 1

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Aflibercept

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Dry age-related macular degeneration

Not recruiting

Investigational

Study of Danicopan for Patients with Geographic Atrophy Due to Age-Related Macular Degeneration

Investigational

France

Participants:18–64 years · 65+ years
Substances:Danicopan

Contact Research Centre

Type IIa hyperlipidaemia

Not recruiting

Investigational

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational

France

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Non-small cell lung cancer stage IV+1

Not recruiting

Registered drugNo placebo

Study on Lorlatinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer After First-line Treatment Failure

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Lorlatinib

Contact Research Centre

Transplant rejection

Not recruiting

InvestigationalNo placebo

Study on Riliprubart for Preventing and Treating Antibody-Mediated Rejection in Adult Kidney Transplant Patients

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Riliprubart

Contact Research Centre

Parkinson's disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson's Disease

Investigational

France

Participants:18–64 years · 65+ years
Substances:N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine

Contact Research Centre

Cardiac amyloidosis+1

Not recruiting

Registered drug

Study on the Effectiveness and Safety of CAEL-101 with Plasma Cell Dyscrasia Treatment in Patients with Stage IIIa AL Amyloidosis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Anselamimab

Contact Research Centre

Primary biliary cholangitis

Not recruiting

Registered drug

Study on the Effects of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis Who Cannot Tolerate Ursodeoxycholic Acid

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Bezafibrate

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.